TrialJournal of translational medicine2025

Glutamine-driven metabolic reprogramming promotes CAR-T cell function through mTOR-SREBP2 mediated HMGCS1 upregulation in ovarian cancer.

Jiannan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.